Publications
2016
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation.
Javaheri T,
Kazemi Z,
Pencik J,
Pham HT,
Kauer M,
Noorizadeh R,
Sax B,
Nivarthi H,
Schlederer M,
Maurer B,
Hofbauer M,
Aryee DN,
Wiedner M,
Tomazou EM,
Logan M,
Hartmann C,
Tuckermann JP,
Kenner L,
Mikula M,
Dolznig H,
Üren A,
Richter GH,
Grebien F,
Kovar H,
Moriggl R.
Cell Death Dis. 2016 Oct 13;7(10):e2419. doi: 10.1038/cddis.2016.268.
2016
8p11 myeloproliferative syndrome: diagnostic challenges and pitfalls.
Antic DA,
Vukovic VM,
Milosevic Feenstra JD,
Kralovics R,
Bogdanovic AD,
Dencic Fekete MS,
Mihaljevic BS.
J BUON. 2016 May-Jun;21(3):745-9.
2016
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.
Vainchenker W,
Kralovics R.
Blood. 2016 Dec 27. pii: blood-2016-10-695940. doi: 10.1182/blood-2016-10-695940.
2016
Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis.
Shimizu T,
Kubovcakova L,
Nienhold R,
Zmajkovic J,
Meyer SC,
Hao-Shen H,
Geier F,
Dirnhofer S,
Guglielmelli P,
Vannucchi AM,
Feenstra JD,
Kralovics R,
Orkin SH,
Skoda RC.
J Exp Med. 2016 Jul 25;213(8):1479-96. doi: 10.1084/jem.20151136.
2016
LNK mutations in familial myeloproliferative neoplasms.
Rumi E,
Harutyunyan AS,
Pietra D,
Feenstra JD,
Cavalloni C,
Roncoroni E,
Casetti I,
Bellini M,
Milanesi C,
Renna MC,
Gotti M,
Astori C,
Kralovics R,
Cazzola M.
Blood. 2016 Jul 7;128(1):144-5. doi: 10.1182/blood-2016-04-711150
2016
The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.
Nivarthi H,
Gordziel C,
Themanns M,
Kramer N,
Eberl M,
Rabe B,
Schlederer M,
Rose-John S,
Knösel T,
Kenner L,
Freund P,
Aberger F,
Han X,
Kralovics R,
Dolznig H,
Jennek S,
Friedrich K,
Moriggl R.
Oncotarget. 2016 May 12. doi: 10.18632/oncotarget.9315.
2016
Thrombopoietin receptor is required for the oncogenic function of CALR mutants.
Nivarthi H,
Chen D,
Cleary C,
Kubesova B,
Jäger R,
Bogner E,
Marty C,
Pecquet C,
Vainchenker W,
Constantinescu SN,
Kralovics R.
Leukemia. 2016 Feb 17. doi: 10.1038/leu.2016.32.
2016
Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans.
Kornienko AE,
Dotter CP,
Guenzl PM,
Gisslinger H,
Gisslinger B,
Cleary C,
Kralovics R,
Pauler FM,
Barlow DP.
Genome Biol. 2016 Jan 29;17(1):14. doi: 10.1186/s13059-016-0873-8.
2016
Cooperation of germline JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia.
Kapralova K,
Horvathova M,
Pecquet C,
Fialova Kucerova J,
Pospisilova D,
Leroy E,
Kralova B,
Milosevic Feenstra JD,
Schischlik F,
Kralovics R,
Constantinescu SN,
Divoky V.
Blood. 2016 Jul 7. pii: blood-2016-02-698951.
2016
Impact of white blood cell counts at diagnosis and during follow-up in patients with essential thrombocythaemia and prefibrotic primary myelofibrosis.
Buxhofer-Ausch V,
Gisslinger B,
Schalling M,
Gleiss A,
Schiefer AI,
Müllauer L,
Thiele J,
Kralovics R,
Gisslinger H.
Br J Haematol. 2016 Jul 19. doi: 10.1111/bjh.14202.
